Current Asthma Research
Severe Eosinophilic Asthma Biologic Injection
Glaxo-Smith Kline: 15-month study investigating a biologic injection that acts just like Fasenra or Nucala but is given just twice a year rather than every 8 or 4 weeks respectively. The purpose is to find a treatment that is more convenient and improves the quality of life for patients with asthma. There will be up to 15 clinic visits during the study period and patients may receive compensation for each visit.
Clinical Study Interest Form
If you are interested in participating in one of our Asthma Clinical Trials, please complete and submit the Interest Form and one of our study coordinators will contact you with more information.